We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi-aventis and the International Union Against Cancer have released an update on the progress of their "My Child Matters Programme," started in 2004 to advance the fight against childhood cancers in developing countries.
Manufacturers of vaccines used to prevent potential avian pandemics
will receive immunity from product liability claims, the U.S. HHS announced recently.
Nautilus Biotech, based in France, has signed a research collaboration and license agreement to discover and develop novel recombinant Factor IX proteins for hemophilia B with Wyeth Pharmaceuticals.
Mitsubishi Chemical Holdings announced that its wholly owned subsidiary, Mitsubishi Pharma, and Tanabe Seiyaku have agreed to merge the two Japanese companies in a deal that will go into effect Oct. 1.
The Global AIDS Alliance has announced that the U.S. Congress has agreed to a major increase in funds to combat AIDS, tuberculosis (TB) and malaria in Africa for fiscal 2007.
Pfizer has entered into an agreement to acquire BioRexis Pharmaceutical, a privately held biopharmaceutical company with a number of diabetes candidates and a novel technology platform for developing new protein drug candidates.
Danish drugmaker Bavarian Nordic announced that it has agreed with GlaxoSmithKline (GSK) to end the companies' collaboration on the production and marketing of Imvamune, a third-generation smallpox vaccine.
Aida Pharmaceuticals has won a patent infringement lawsuit against four Chinese drug companies over their copies of Aida's antibiotic etimicin sulfate.